Pharmacy Report Archives - Page 18 of 139 - Becker's Hospital Review

UVA to open central pharmacy | CVS taps 2 new execs | FDA to research firm: Redo drug studies | Walgreens posts $5.6B Q2 loss | 25 systems with strong finances

April 8, 2025 BHR Newsletter 1. Walgreens posts $5.6B operating loss in Q2 Full story 2. FDA tells research company to redo studies Full story 3. UVA Health to build central pharmacy center Full story 4. 24/7/365 telepharmacy prevents mistakes…

Tariffs + hospital pharmacies: What to know | CVS' top-paid execs | FTC resumes PBM probe | CMS finalizes drug event reporting deadlines | Mounjaro outperforms Trulicity in study

April 7, 2025 BHR Newsletter 1. CVS Health's highest-paid executives Full story 2. Tariffs and hospital pharmacies: What to know Full story 3. CMS finalizes deadlines for prescription drug event records Full story 4. Avoid costly coding mistakes. Learn how…

FTC pauses PBM probe | Tool aids adverse drug event detection | 10 systems seeking pharmacy leaders | FDA trims drug inspection plans | Pharma skirts tariffs — for now

April 3, 2025 BHR Newsletter 1. FDA planning fewer drug inspections due to layoffs Full story 2. Pharma tariffs exempt for now: 4 things to know Full story 3. FTC pauses case against top PBMs Full story 4. Take the…

Pharma braces for reciprocal tariffs | Yale New Haven opens 6th retail pharmacy | 37 healthcare billionaires | Ovarian cancer drug candidate shows potential | PBM 2025 formularies: What to know

April 2, 2025 BHR Newsletter 1. Study finds new drug effective against treatment-resistant ovarian cancer Full story 2. Trump's reciprocal tariffs near: 5 things to know Full story 3. Yale New Haven Health opens retail pharmacy Full story 4. The shift…

Pharmacy experience shapes new CFO | Top PBMs by market share | Court: Colo. can limit Rx prices | Eli Lilly expands GLP-1 access | U of Calif. pharmacist strike begins

April 1, 2025 BHR Newsletter 1. How an Orlando Health hospital CFO bridged pharmacy and finance leadership Full story 2. 3 senators join 340B program support group Full story 3. Judge allows Colorado to limit prescription drug prices Full story…

Pa. system adds 2 pharmacists to C-suite | How 3 systems reinvest 340B savings | MultiCare rolls out Rx kiosks | Eli Lilly drug shows promise in heart trial | What hospitals can't risk to improve margins

March 31, 2025 BHR Newsletter 1. Experimental Eli Lilly drug cuts heart disease risk Full story 2. How 3 health systems are leveraging 340B savings Full story 3. Health system CFOs fight for Medicaid on Capitol Hill Full story 4.…

Ind. system opens $10M central pharmacy | HHS to lay off 10K workers | 10 systems seeking pharmacy leaders | Reciprocal tariffs: 5 details | 6 GLP-1 updates

March 27, 2025 BHR Newsletter 1. Indiana system launches automated central pharmacy Full story 2. Amazon Pharmacy executive exits Full story 3. 6 GLP-1 updates Full story 4. Hospitals are using tech to streamline IDR arbitration. See how, here. 5. HHS…

Oschner Children's targets Rx errors | 1st UTI antibiotic approved in 30 years | Specialty drug spend falls to 2nd place | A crossroads for GLP-1s | Gender pay gap shrinks

March 26, 2025 BHR Newsletter 1. Ochsner Children's, ISMP partner on pharmacist training, medication safety Full story 2. GLP-1s outpace specialty drug spend for the first time: Report Full story 3. FDA approves antibiotic to treat UTIs for 1st time in…

3 systems' strategy for ultrahigh-cost drugs | U of Calif. pharmacists to strike again | Will GLP-1 compounding stop? | Okla. system CEO, CFO resigns | 10 hospitals with longest ED visit times

March 25, 2025 BHR Newsletter 1. Health systems' strategy for ultrahigh-cost drugs Full story 2. Novo Nordisk expands access to reduced-cost Wegovy Full story 3. 10 most, least stressed states Full story 4. CommonSpirit, Duke + Ballad Health cracked the code…

6 innovators on leadership, growth | 8 deaths tied to drug plant | Novo strikes $2B deal for obesity drug | Why hospital closures are rising | 46% of healthcare execs eye exit

March 24, 2025 BHR Newsletter 1. 6 pharmacy visionaries on leadership and growth Full story 2. FDA finds cleaning, testing issues at drug plant linked to 8 deaths Full story 3. Novo Nordisk to pay up to $2B for experimental…